TWST
Twist Bioscience Delivers Strong Q2 Results, Exceeding Market Expectations
In its recently reported second quarter financial results conference call, Twist Bioscience demonstrated another strong performance, extending its track record of consistent execution with 13 consecutive quarters of sequential revenue growth. The company's CEO and Co-founder, Dr. Emily Leproust, highlighted the success of their semiconductor-based DNA synthesis platform,